Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05TUL
|
|||
| Former ID |
DIB004023
|
|||
| Drug Name |
MB-11316
|
|||
| Indication | Injury [ICD-11: NA00-ND5Z] | Phase 2 | [1] | |
| Company |
Mazence Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Mazence Inc. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.